Clinical trials
Active, not recruiting Observational Acquired Immunodeficiency Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 2 |
| Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | 1 |
| Erasmus Medical Center | 1 |
| FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE | 1 |
| Johns Hopkins University | 1 |
| Midway Specialty Care Center | 1 |
| National Cancer Institute (NCI) | 1 |
| Rigshospitalet, Denmark | 1 |
| Southwest Medical University | 1 |
| University Hospital Virgen de las Nieves | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 13 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Bone Diseases, Metabolic | 1 |
| COVID-19 | 1 |
| Inflammation | 1 |
| Injection Site Reaction | 1 |
| Lymphoma, Primary Effusion | 1 |
| Sarcoma, Kaposi | 1 |
| Squamous Intraepithelial Lesions | 1 |
| Substance-Related Disorders | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.